About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(CAG-cre/Esr1*)1Egwa
transgene insertion 1, Gyohei Egawa
MGI:4430073
Summary 4 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Plxnd1tm1Ddg/Plxnd1tm1.1Tmj
Tg(CAG-cre/Esr1*)1Egwa/0
involves: 129S/SvEv * C57BL/6 * DBA/2 MGI:5052373
cn2
Kdrtm1Jrt/Kdrtm1.1Jamb
Tg(CAG-cre/Esr1*)1Egwa/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2 MGI:5052372
cn3
Efnb2tm2And/Efnb2tm2And
Tg(CAG-cre/Esr1*)1Egwa/0
involves: 129S7/SvEvBrd * C57BL/6 * DBA/2 MGI:4430085
cn4
Gt(ROSA)26Sortm1(CAG-Rhoj,-EGFP)Auem/Gt(ROSA)26Sortm1(CAG-Rhoj,-EGFP)Auem
Tg(CAG-cre/Esr1*)1Egwa/0
involves: C57BL/6 * CBA * DBA/2 MGI:5052370


Genotype
MGI:5052373
cn1
Allelic
Composition
Plxnd1tm1Ddg/Plxnd1tm1.1Tmj
Tg(CAG-cre/Esr1*)1Egwa/0
Genetic
Background
involves: 129S/SvEv * C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Plxnd1tm1.1Tmj mutation (1 available); any Plxnd1 mutation (87 available)
Plxnd1tm1Ddg mutation (0 available); any Plxnd1 mutation (87 available)
Tg(CAG-cre/Esr1*)1Egwa mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype

Increase in extraretinal vascular outgrowth in ischemic Plxnd1tm1.1Tmj/Plxnd1tm1Ddg Tg(CAG-cre/Esr1*)1Egwa/0 retinas

vision/eye
• tamoxifen-treated mice exhibit increased extraretinal vascular outgrowth in ischemic retinas compared with control mice

cardiovascular system
• tamoxifen-treated mice exhibit increased extraretinal vascular outgrowth in ischemic retinas compared with control mice




Genotype
MGI:5052372
cn2
Allelic
Composition
Kdrtm1Jrt/Kdrtm1.1Jamb
Tg(CAG-cre/Esr1*)1Egwa/0
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Kdrtm1.1Jamb mutation (0 available); any Kdr mutation (74 available)
Kdrtm1Jrt mutation (1 available); any Kdr mutation (74 available)
Tg(CAG-cre/Esr1*)1Egwa mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype

Suppression of of extraretinal vascular outgrowth in ischemic Kdrtm1.1Jamb/Kdrtm1Jrt Tg(CAG-cre/Esr1*)1Egwa/0 retinas

cardiovascular system
• tamoxifen-treated mice exhibit decreased extraretinal vascular outgrowth in ischemic retinas compared with control mice

vision/eye
• tamoxifen-treated mice exhibit decreased extraretinal vascular outgrowth in ischemic retinas compared with control mice




Genotype
MGI:4430085
cn3
Allelic
Composition
Efnb2tm2And/Efnb2tm2And
Tg(CAG-cre/Esr1*)1Egwa/0
Genetic
Background
involves: 129S7/SvEvBrd * C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Efnb2tm2And mutation (2 available); any Efnb2 mutation (29 available)
Tg(CAG-cre/Esr1*)1Egwa mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• some pups become frail and subsequently die with tamoxifen treatment on first two days postnatal

growth/size/body
• seen with tamoxifen treatment on first two days postnatal

cardiovascular system
• with tamoxifen treatment, vascular morphology in the dermis is severely affected, with dilatation of the vascular lumen

integument
N
• with tamoxifen treatment, infiltration of leukocytes is comparable to untreated controls and is not cause of hypercornification
• seen at P9 with tamoxifen treatment on first two days postnatal
• seen at P9 seen with tamoxifen treatment on first two days postnatal
• seen with tamoxifen treatment on first two days postnatal, pups have shorter hair follicles
• hypercornification of skin is observed seen at P9 with tamoxifen treatment on first two days postnatal
• with tamoxifen treatment, no difference is detected at P4
• seen at P9 with tamoxifen treatment on first two days postnatal
• observed initially by P5 and peaking between 1 and 2 weeks of age with tamoxifen treatment on first two days postnatal
• enhanced proliferation of epidermal progenitor cells is detected with tamoxifen treatment at P1-2




Genotype
MGI:5052370
cn4
Allelic
Composition
Gt(ROSA)26Sortm1(CAG-Rhoj,-EGFP)Auem/Gt(ROSA)26Sortm1(CAG-Rhoj,-EGFP)Auem
Tg(CAG-cre/Esr1*)1Egwa/0
Genetic
Background
involves: C57BL/6 * CBA * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(CAG-Rhoj,-EGFP)Auem mutation (0 available); any Gt(ROSA)26Sor mutation (992 available)
Tg(CAG-cre/Esr1*)1Egwa mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype

Decreased extraretinal vascular outgrowth in ischemic Gt(ROSA)26Sortm1(CAG-Rhoj,-EGFP)Auem/Gt(ROSA)26Sortm1(CAG-Rhoj,-EGFP)Auem Tg(CAG-cre/Esr1*)1Egwa/0 retinas

cardiovascular system
• tamoxifen-treated mice exhibit decreased extraretinal vascular outgrowth in ischemic retinas compared with control mice

vision/eye
• tamoxifen-treated mice exhibit decreased extraretinal vascular outgrowth in ischemic retinas compared with control mice





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
10/29/2024
MGI 6.24
The Jackson Laboratory